Donald Vinh, MD: AstraZeneca: Advisor/Consultant (Terminated, October 24, 2022), Honoraria (Terminated, October 24, 2022); GSK: Board Member (Terminated, May 12, 2022); Merck & Co., Inc.: Board Member (Terminated, January 8, 2024); Moderna, Inc.: Advisor/Consultant (Ongoing); Takeda: Board Member (Ongoing), Honoraria (Ongoing); Xediton: Board Member (Terminated, February 16, 2024)